Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
H Died in Health Professions & Programs Subcommittee
Email me when HB 1381 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 1381. By continuing you agree to the Terms and Privacy Policy.
Summary
The Promising Pathways Act would let licensed doctors prescribe, and qualified hospitals administer, experimental drugs, biologics, or devices that have passed Phase 1 trials but lack FDA approval. It requires strict informed‑consent, IRB‑approved protocols, a statewide patient registry, and sets up limited reimbursement and insurance‑coverage incentives. The bill aims to give seriously ill patients more options while collecting safety data.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 1381
3 free questions a day, no accountHistory
- Died in Health Professions & Programs Subcommittee
- Referred to Health Professions & Programs Subcommittee
- Referred to Health Care Budget Subcommittee
- Referred to Health & Human Services Committee
- Now in Health Professions & Programs Subcommittee
- 1st Reading (Original Filed Version)
- Filed
Sponsors
- Franklin · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 1381 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 1381 freeOr ask your AI assistant about HB 1381 directly:
Add to Claude, ChatGPT or Cursor